NCT03290365View on ClinicalTrials.gov

The Combination Effect of Platelet-rich Plasma and Hyaluronic Acid for Knee Osteoarthritis

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 10, 2018

Primary Completion Date

July 1, 2021

Study Completion Date

July 1, 2021

Conditions
Knee Osteoarthritis
Interventions
DRUG

platelet rich plasma + Hyaluronic acid

Platelet rich plasma (PRP) and Hyaluronic acid (HA) are beneficial for patients with osteoarthritis of knee.

DRUG

platelet rich plasma + normal saline

The normal salin as the placebo intervention was injection control group.

Trial Locations (1)

886

Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital, Taipei

All Listed Sponsors
lead

Tri-Service General Hospital

OTHER

NCT03290365 - The Combination Effect of Platelet-rich Plasma and Hyaluronic Acid for Knee Osteoarthritis | Biotech Hunter | Biotech Hunter